Summit Therapeutics Inc. Common Stock (SMMT) News
Latest headlines that mention SMMT, newest first · each headline opens the original publisher
- Last price
- $17.17
- Day change
- -4.35%
- Next earnings
- 2026-10-19
SMMT headlines
last 30 daysSummit Therapeutics stock jumped Tuesday after AstraZeneca made a $2 billion investment in the smaller biotech. The post AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck appeared first on Investor's Business Daily .
Summit shares surged in after-hours trading following the news of AstraZeneca’s investment, as the two companies plan to ramp up their collaboration on developing cancer treatments.
Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.
Also mentioned with SMMT
30dHeadlines that tag both tickers
SMMT news alerts
Get an alert by email or push when a new headline mentions SMMT.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.